Our Eligibility & Screening Criteria in Roundup Cases
At Atraxia Media, we have a proven track record of providing contracts that meet our clients' needs. We are highly familiar with Roundup cases and can assist you in launching your Roundup campaign and obtaining signed contracts for your firm. As a result, we can assist with implementing a marketing campaign that will include:
- Pre-screening. Spending time onboarding clients that aren't a good fit for your organization is the quickest way to squander time on client intake. As such, we understand that not every situation or individual is a good fit for you, and focus on finding the claimants that fit your law firm's criteria.
- Screening each case. We design straightforward inquiries to get to the heart of a potential Plaintiff's situation. Our goal is the same as yours: to prove these cases.
- Following up with potential Roundup clients. We create a follow-up schedule to keep the intake process efficient and effective.
- Delivering signed contracts to your law firm. Attorneys tell us that our cases generally turn out better than those handled by other firms providing similar services.
- Connecting you with a bigger volume of prospective Roundup claimants. We assist your law firm in increasing the number of cases that fit your focus and budget.
- Running in-house case-generating marketing techniques. As leads come in, they are routed to our internal intake department, where they are vetted based on your criteria.
- Signing potential Roundup Plaintiffs exclusively for your law firm.
Farmers, agricultural workers, professional gardeners, and others are eligible to file a Roundup claim if they:
- Were exposed to Roundup frequently
- Were diagnosed with Non-Hodgkin's lymphoma or another glyphosate-related cancer
At Atraxia Media, we have extensive expertise in advertising and handling Roundup cases. As a result, if you're a lawyer interested in this campaign, we'd be delighted to assist you. We offer a proven track record of achieving volume, low costs, and the ability to sign potential clients according to your specifications. Furthermore, our internal intake staff will review and sign all cases exclusively for you.
Roundup Facts & History
More than 4,000 Roundup cases are currently pending in the federal court system. More cases are expected to be filed in the MDL, while over 65,000 cases are active in state courts.
In its 2020 annual report, Bayer indicated that it had settled 88,500 of the estimated 125,000 Roundup claims disclosed in 2020. However, the company faces tens of thousands of lawsuits pending in courts nationwide and will likely continue to face new claims as individuals diagnosed with cancer come forward.
Roundup, manufactured by Monsanto, is the most extensively used glyphosate-based herbicide worldwide. But the weed killer has been linked to an increased risk of non-Hodgkin lymphoma (NHL) or other cancers, especially among those who work in farming and agriculture. Roundup and other glyphosate-based herbicides were acquired by the German company Bayer AG in 2018 through a $63 billion takeover of Monsanto.
ROUNDUP PRODUCTS LIABILITY LITIGATION, MDL NO. 2741
Location:
- Northern District of California (San Francisco)
Presiding Judge:
Plaintiffs:
- Dewayne Johnson
- Edwin Hardeman
- Alva Pilliod
- Alberta Pilliod
Executive Committee:
- Michael L. Baum of Baum Hedlund Aristei Goldman, PC in California
- Robin Greenwald of Weitz & Luxenberg, PC in New York
- Michael Miller of The Miller Firm, LLC in Virginia
- Aimee Wagstaff of Andrus Wagstaff, PC in Colorado
- Hunter Lundy of Lundy Lundy Soileau & South in Louisiana
- Yvonne Flaherty of Lockridge Grindal Nauen in Minnesota
Defendants:
Products:
Plaintiff Allegations:
The Plaintiffs seek financial compensation for personal injuries suffered following exposure to Roundup Weed Killer, which stems from non-Hodgkin's lymphoma, B or T-Cell lymphoma, chronic lymphocytic leukemia, hairy cell lymphoma, and mantle cell lymphoma. The companies failed to warn people of the potential carcinogenic effects of the product.
History:
2025:
- There are 4,432 pending MDL dockets in the Roundup Product Liability Litigation. Over 65,000 cases remain active in different state courts nationwide.
- On May 9, another appeal by Monsanto was denied. The company tried to appeal the $175 million verdict awarded to an 83-year-old restaurant owner in October 2023.
- A new lawsuit was filed by a Mississippi resident, alleging that his non-Hodgkin lymphoma diagnosis was caused by decades of glyphosate exposure from Roundup herbicide. The complaint alleged that Roundup was defectively designed and mislabeled.
- Bayer petitioned the U.S. Supreme Court to block Roundup cancer lawsuits. In its argument, federal law preempts state failure-to-warn claims, citing that the EPA does not require a cancer warning on glyphosate labels.
- March: A jury in Georgia awarded around $2.1 billion to a plaintiff for damages related to his non-Hodgkin's lymphoma after Roundup herbicide use. The verdict was around $65 million in compensatory damages and $2 billion in punitive damages. The evidence included years of 'cover-up' and 'backroom dealings' done by the manufacturer to deny any connection between the herbicide and NHL.
2024:
- By October 2024, Monsanto had reached settlements in more than 100,00 claims, totalling around $11 billion in payouts.
- A Philadelphia jury awarded $78 million to a Pennsylvania resident who alleged that he developed non-Hodgkin's lymphoma after using Roundup products.
- September: In September 2024, Bayer scored a win amid billions of payouts in lawsuits and settlements. A Philadelphia jury ruled in favor of the defendant, citing that the plaintiff did not have enough evidence to claim that the herbicide manufacturer was liable for their non-Hodgkin's lymphoma diagnosis.
- August: After losing their argument in the Ninth and Eleventh Circuits, Bayer finally found a win when it appealed to the Third Circuit Court of Appeals. The Third Circuit ruled that failure-to-warn claims against Bayer were not allowed in state courts, contradicting the decision of two other federal courts. The case involved was settled in 2022, involving a lawsuit by a professional landscaper diagnosed with non-Hodgkin's lymphoma after using Roundup in his job and at his home. This third appeal by Bayer created a circuit split, meaning that the matter may be raised to the Supreme Court.
- July: An Oregon appeals court ruled that a plaintiff's expert was improperly barred from testifying in a Roundup cancer trial. The court remanded the case for a new trial.
- April: A Missouri judge reduced a $1.56 billion Roundup verdict against Bayer to $611 million because punitive damages generally did not exceed nine times the compensatory damages. Punitive damages were reduced to $549.9 million, while compensatory damages remained at $61.1 million.
- January: A Philadelphia jury awarded $2.25 billion to a plaintiff who developed non-Hodgkin's lymphoma from using Roundup, with $25 million in compensatory and $150 million in punitive damages. The Philadelphia Court of Common Pleas would later reduce the punitive damages verdict to $400 million in total.
2023:
- October: An 83-year-old retired restaurant owner was awarded a $175 million verdict with $25 million in compensatory damages and $150 million in punitive damages. The plaintiff alleged that his non-Hodgkin lymphoma was caused by using Roundup products by the defendant.
- April: Approximately 4,143 lawsuits remained open in federal multidistrict litigation in California. Roundup lawyers are still accepting claims to potentially go to trial or to negotiate a settlement. While Bayer offered a $10.9 billion settlement to resolve approximately 100,000 Roundup lawsuit claims in 2020, in 2021, a San Francisco judge denied Bayer's Roundup class-action lawsuit offer to settle future Roundup claims for $2 billion.
2022:
- August: Monsanto has settled over 100,000 Roundup lawsuits, paying out roughly $11 billion as of May 2022. There are still 30,000 lawsuits pending. This includes 4,000 cases in multidistrict litigation in California. In one case, a person used Roundup for over three decades. The jury awarded the individual $2 billion in damages, but a court later reduced that to $86.7 million, claiming the original amount was excessive.
2021:
- June: Judge Vincent Chhabria rejected Bayer's $2 billion plan to settle future lawsuits, calling it "unreasonable". In consequence, the company now considers a silent Roundup recall: the removal of glyphosate as the active ingredient in residential versions of Roundup sold in the U.S., essentially removing the ingredient from store shelves. However, it appears that Bayer would continue to promote the Roundup brand associated with a different weedkiller.
- May: In the first Roundup federal bellwether trial, a U.S. appeals court rejected an attempt to overturn the $25 million compensatory damages. The Court upheld the verdict awarded in 2019, as well as $20 million in punitive damages.
- March: Roundup manufacturer said it will not ask for the overturn of a $20.5 million verdict awarded to a school groundskeeper in the first claim that went before a jury in 2018.
- February: The Roundup manufacturer has increased the compensation that it will pay to resolve cases diagnosed over the next four years. The decision came after a federal Judge previously signaled that an attempt to bind individuals not yet diagnosed with non-Hodgkin lymphoma from Roundup to a class-action settlement might not be proper or fair.
- January: Judge Vincent Chhabria cleared the way for a new round of bellwether trials. This suggests that trials continue while Bayer is still trying to negotiate settlements in tens of thousands of claims brought by former Roundup users.
2020:
- December: The Honorable Judge Vincent Chhabria issued updated scheduling orders, which call for dozens of cases to resume preparations for trial since the parties now report that less than half of all cases pending in the federal court system are subject to a signed agreement.
- November: Roundup manufacturer missed a key deadline to finalize deals and indicated it expects the cost associated with future lawsuits and litigation to rise, although it had earlier announced that settlements had been reached to settle most U.S. lawsuits.
- August:
- Most of the settlements unraveled after Bayer earlier agreed to resolve thousands of lawsuits brought over Monsanto's Roundup herbicide with $10.9 billion in settlements.
- The Honorable Judge Vincent Chhabria gave lawyers until Sept. 24 but said he might lift the stay on litigation and set cases for trial.
- July:
- The Honorable Judge Vincent Chhabria agreed to stay the MDL proceedings until November.
- A California appeals court determined that Bayer and its Monsanto subsidiary should pay $20.5 million in compensation to a California groundskeeper who developed non-Hodgkin's lymphoma from Roundup, rejecting the manufacturer's attempt to reverse a lower court verdict entirely.
- June:
- Bayer agreed to a $10.9 billion settlement over Monsanto's weedkiller Roundup.
- The Honorable Judge Vincent Chhabria set a hearing for late July to consider a motion for approval of a class-action settlement set to provide more than $1.1 billion for the benefit of individuals exposed to Roundup, who were not yet diagnosed with cancer.
- May:
- A group of 41 cases originally filed in Hawaii and Texas was selected by the parties for the third wave of case-specific discovery.
- A request to appoint a lead lawyer who was intended to handle the interests of class-action Plaintiffs was rejected by the Honorable Judge Vincent Chhabria.
- April: In a claim filed in Ohio, the Plaintiff indicated he was diagnosed with hairy-cell leukemia following exposure to Roundup.
- March:
- A court-appointed mediator continued to work with Bayer and Plaintiffs' lawyers to settle Roundup lawsuits.
- Several non-profit organizations filed a false advertising lawsuit against Nestle Purina, alleging the company misled consumers by claiming that its Beyond Natural cat food products did not contain artificial preservatives, despite the presence of Roundup residue.
- A growing number of environmental groups and consumer watchdogs filed lawsuits against the U.S. Environmental Protection Agency (EPA) 's controversial decision to reapprove the use of the weedkiller and other products with the active ingredient glyphosate. These groups are the Rural Coalition, Farmworker Association of Florida, Beyond Pesticides, the Center for Food Safety (CFS), and the Organizacion En California De Linderes Campesinas.
- The Plaintiff, who won the federal bellwether trial over the non-Hodgkin lymphoma from Roundup, asked an appeals court to not only reject Bayer and Monsanto's efforts to overturn that victory but also to reinstate the full $75 million in punitive damages.
- The U.S. District Judge presiding over the litigation has agreed to push back various deadlines in the litigation and vacated a trial set to begin in March 2020.
- February: The U.S. District Judge presiding over the Roundup MDL has postponed the start of a bellwether trial and extended deadlines for other Roundup claims, as the parties continued to engage in mediation.
- January: In a landmark trial in St. Louis, lawyers involved in the litigation continued to negotiate with Bayer about a potential Roundup settlement.
2019:
- December: Bayer and its Monsanto subsidiary were set to face a steady stream of additional trial dates in 2020 unless they reached a settlement to resolve claims.
- November: The Honorable Judge Vincent Chhabria decided to remand two cases back to the state courts where they were originally filed, for further proceedings and individual trial schedules.
- October: In a product liability lawsuit, an Ohio woman indicated that she was diagnosed with diffuse large B-cell lymphoma linked to the Roundup weedkiller.
- September: In three product liability lawsuits, the Plaintiffs alleged that large B-cell lymphoma, chronic lymphocytic leukemia, and non-Hodgkin lymphoma were caused by exposure to the weedkiller Roundup.
- July: In a product liability lawsuit, an Arkansas woman claimed that decades of exposure to Roundup resulted in the diagnosis of non-Hodgkin's lymphoma.
- June: The Honorable Judge Vincent Chhabria identified nearly 60 cases originating in four different states, which were to be prepared for remand and individual trial dates.
- May: A $2 billion verdict was awarded in the first CA JCCP trial, Pilliod et al. v. Monsanto, to a husband and wife diagnosed with non-Hodgkin's lymphoma. They blamed their cancer on the use of Roundup. The verdict was later trimmed to $86.7 million.
- February: $5 million in compensatory damages and $75 million in punitive damages were awarded by a jury in San Francisco in the first federal trial, Hardeman v. Monsanto, to a Plaintiff who used Roundup for decades and developed cancer. Later, the award was reduced to $25 million.
2018:
- August: A $289 million verdict was awarded in the first-ever trial, Johnson v. Monsanto, by a California state court to a former school groundskeeper diagnosed with terminal cancer. In a final judgment, the verdict was reduced to around $78 million. In July 2020, a California appeals court determined that Bayer and Monsanto should pay $20.5 million in compensation to the California groundskeeper.
